The Female Self-Advocacy in Cancer Survivorship Scale: A validation Study
Overview
Authors
Affiliations
Aim: To develop and psychometrically test the validity of the Female Self-Advocacy in Cancer Survivorship Scale.
Background: Female cancer survivors need to self-advocate to overcome challenges associated with cancer yet no valid measure of self-advocacy exists.
Design: Instrument development. Mixed-mode cross-sectional survey design.
Participants: We recruited adult females (18+ years; N = 317) with a history of invasive cancer from local and national tumour registries and advocacy organizations to complete online or paper questionnaires.
Methods: Between July 2014 - March 2015 to evaluate the construct validity based on evidence of the scale's: (1) internal structure consistent with the underlying model of self-advocacy; (2) sensitivity to differences between groups known to differ in self-advocacy skills; (3) relationships between self-advocacy and key potential predictors (openness and conscientiousness; information engagement; social support) and outcomes (symptom burden and healthcare utilization); (4) relationships between self-advocacy and related concepts (patient activation; self-advocacy within another patient population); and (5) relationships between self-advocacy and criterion measures. Analyses included an exploratory factor analysis, t tests, and bivariate correlations using validated, reliable measures for constructs.
Results: Evidence from all five hypotheses supported the construct validity of the Female Self-Advocacy in Cancer Survivorship Scale. The factor analysis confirmed the three underlying dimensions of self-advocacy resulting in a 20-item measure with strong internal consistency that explained almost half of response variance.
Conclusion: The Female Self-Advocacy in Cancer Survivorship Scale is a valid, reliable measure of how well adult female cancer survivors can get their needs met in the face of adversity.
Okado I, Braun-Inglis C, Matsumoto K, Elhajj C, Cassel K, Berenberg J J Cancer Educ. 2024; .
PMID: 39636502 DOI: 10.1007/s13187-024-02550-6.
Lazris D, Donovan H, Scott P, Nilsen M, Thomas T J Cancer Educ. 2024; .
PMID: 39487933 DOI: 10.1007/s13187-024-02536-4.
Haag S, Schaffer J SAGE Open Nurs. 2024; 10:23779608241281132.
PMID: 39380928 PMC: 11459495. DOI: 10.1177/23779608241281132.
Thomas T, Scott P, Nilsen M, Lee J, McCarthy M, Harris A Psychooncology. 2023; 33(1):e6269.
PMID: 38095337 PMC: 10872533. DOI: 10.1002/pon.6269.
Describing Self-Advocacy in Underrepresented Women With Advanced Cancer.
Bell S, Bergeron R, Murray P, Gazaway S, Thomas T Oncol Nurs Forum. 2023; 50(6):725-734.
PMID: 37874756 PMC: 11195808. DOI: 10.1188/23.ONF.725-734.